7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2014-12-31 2014-09-30 2014-06-30 2013-12-31 2013-09-30 2013-06-30 2012-12-31 2012-09-30 2012-06-30 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 
      
    		                                                      
      cash flows from operating activities:
    		                                                      
      net income
    		41,700,000 -18,600,000 -154,600,000 -53,600,000 78,400,000 129,300,000 154,700,000 419,200,000 666,600,000 666,400,000 604,000,000 580,300,000 546,200,000 507,200,000 437,900,000 352,800,000 242,000,000 252,800,000 116,000,000 36,200,000 73,600,000 123,600,000 99,900,000 311,100,000 108,900,000 50,700,000 174,700,000 49,200,000 96,300,000 35,700,000 146,743,000 -251,086,000 189,156,000 170,587,000 107,175,000 33,919,000 -113,363,000 61,211,000 64,899,000 130,460,000 84,798,000 92,038,000 89,909,000 105,401,000 99,806,000 78,579,000 10,173,000 -21,184,000 78,710,000 77,489,000 79,287,000 99,293,000 125,528,000 100,776,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                                      
      depreciation and amortization
    		172,700,000 171,100,000 187,000,000 186,800,000 187,600,000 188,700,000 218,200,000 219,400,000 219,000,000 222,900,000 243,200,000 244,000,000 251,800,000 259,400,000 293,200,000 300,600,000 277,500,000 272,200,000 287,800,000 286,900,000 285,800,000 292,800,000 310,900,000 300,000,000 297,600,000 307,100,000 238,700,000 243,900,000 221,000,000 172,800,000 156,868,000 154,676,000 152,555,000 151,801,000 114,968,000 112,816,000 113,141,000 76,178,000 71,109,000 60,375,000 73,303,000 70,821,000 60,988,000 45,242,000 48,052,000 50,410,000 64,012,000 51,211,000 25,245,000 24,642,000 25,177,000 25,351,000 26,459,000 27,177,000 
      deferred income taxes
    		5,300,000 -3,000,000 -17,500,000 -76,100,000 -41,600,000 -8,100,000 -71,300,000 17,100,000 3,100,000 23,900,000 20,100,000 54,100,000 56,600,000 74,700,000 1,800,000 17,300,000 -31,300,000 20,100,000 -56,000,000 -34,800,000 1,300,000 -49,400,000 -86,100,000 -293,300,000 -94,100,000 -16,800,000 -33,100,000 42,500,000 -158,800,000 87,200,000 -16,355,000 114,494,000 -25,061,000 -21,878,000 -34,395,000 -50,726,000 32,906,000 24,883,000 -18,490,000 -17,509,000 10,292,000 -2,178,000 -2,319,000 12,318,000 6,574,000 5,298,000 -556,000 -12,352,000 2,927,000 99,000 358,000 6,728,000 6,623,000 4,086,000 
      share-based compensation expense related to equity incentive plans
    		61,600,000 52,900,000 40,700,000 49,400,000 46,300,000 44,000,000 42,800,000 44,800,000 45,400,000 44,500,000 43,900,000 44,000,000 41,300,000 41,200,000 47,000,000 50,900,000 55,700,000 56,600,000 55,000,000 51,200,000 49,700,000 42,400,000 40,700,000 43,500,000 45,300,000 40,700,000 38,900,000 39,600,000 42,600,000 45,300,000 23,179,000 24,003,000 23,610,000 22,408,000 22,120,000 24,390,000 59,579,000 16,965,000 23,026,000 14,112,000 14,819,000 15,273,000 13,321,000 13,719,000 15,000,000 12,656,000 14,120,000 14,607,000 9,986,000 9,962,000 9,484,000 9,024,000 9,027,000 9,409,000 
      amortization of debt discount
    		5,300,000 1,400,000 13,200,000 23,500,000 11,500,000 16,600,000 18,700,000 14,000,000 3,100,000 1,700,000 1,800,000 1,800,000 1,800,000 1,800,000 10,000,000 10,700,000 11,600,000 12,600,000 13,600,000 14,400,000 17,800,000 25,300,000 30,800,000 30,700,000 30,300,000 29,900,000 29,400,000                            
      amortization of debt issuance costs
    		1,300,000 1,400,000 1,700,000 1,800,000 2,300,000 2,000,000 1,600,000 1,700,000 1,800,000 2,200,000 2,400,000 2,400,000 2,400,000 2,300,000 2,300,000 2,800,000 2,900,000 3,500,000 3,900,000 4,200,000 4,200,000 4,800,000 4,300,000 4,300,000 4,300,000 4,200,000 4,400,000 3,700,000 5,400,000 3,000,000 1,648,000 1,613,000 1,718,000 1,621,000 1,064,000 1,061,000 1,057,000 996,000 962,000 958,000 544,000 544,000 544,000 544,000 545,000 327,000         
      impairment of intangible assets
    		300,000 2,200,000     500,000 200,000 600,000 500,000 400,000            1,700,000 0 0 500,000 0 0 1,100,000 2,000,000 248,000 37,000 87,000 128,000 8,242,000 0 1,984,000 47,000   1,305,000 150,000 406,000 0           
      other
    		4,800,000 -600,000 -17,500,000 -21,200,000 -5,900,000 -18,400,000 -14,400,000                                                
      changes in operating assets and liabilities, excluding impact of acquisitions:
    		                                                      
      increase in accounts receivable
    		19,900,000 -75,800,000      308,100,000 -241,200,000 -159,700,000 -130,300,000 -41,800,000 11,800,000 -72,400,000    -3,000,000        -56,200,000    -55,200,000 -10,538,000 -7,719,000   -18,119,000 -15,531,000 -9,901,000   -3,096,000  7,818,000 -37,247,000  1,769,000 -2,462,000  2,698,000 -2,814,000   -15,052,000  15,487,000 
      decrease (increase) in inventories
    		     9,200,000 -3,400,000              -3,500,000 24,900,000     -2,900,000 83,000,000 177,700,000 83,800,000      94,848,000 121,102,000    -3,368,000 7,061,000 24,991,000    24,812,000 22,018,000 316,000      
      decrease in accounts payable and accrued liabilities
    		                 -900,000      -44,900,000           -244,000   -12,991,000   -23,184,000   -19,864,000   -30,869,000        
      change in other assets and liabilities
    		-72,400,000 -3,400,000 34,600,000 -22,700,000 -29,300,000 -20,700,000 -107,600,000 -20,500,000 13,400,000 50,500,000 -3,500,000 418,600,000 32,200,000 -42,800,000 49,100,000 -8,800,000 11,600,000 27,500,000 6,600,000 -41,900,000 17,200,000 1,400,000 -9,200,000 -3,000,000 -15,300,000 14,400,000 -39,400,000 40,300,000 63,500,000 -88,600,000 -1,663,000 -1,058,000 24,017,000 -7,296,000 -625,000 -1,371,000 -12,270,000 -33,688,000 1,364,000 5,225,000 -18,486,000 -5,113,000 15,850,000 -10,392,000 5,214,000 14,977,000 -7,462,000 35,171,000 5,291,000 1,123,000 24,890,000 -10,873,000 -43,785,000 4,287,000 
      change in income tax payable
    		-174,800,000 -4,600,000 -8,300,000 67,300,000 -88,600,000 27,800,000 60,200,000 -72,400,000 -133,300,000 107,000,000 -12,000,000 26,000,000 -17,600,000 -24,400,000 -10,100,000 45,800,000 -27,400,000 6,500,000 34,900,000 4,200,000 -38,400,000 16,700,000 18,000,000 -22,900,000 -11,500,000 -24,100,000 -27,300,000 -70,200,000 -79,400,000 -13,900,000 63,997,000                        
      net cash from operating activities
    		88,100,000 275,600,000 205,900,000 271,500,000 43,600,000 377,100,000 430,000,000 853,300,000 616,200,000 993,200,000 709,500,000 1,277,900,000 793,200,000 840,400,000 747,700,000 853,400,000 611,700,000 629,900,000 449,200,000 509,700,000 455,800,000 501,800,000 371,700,000 395,500,000 396,000,000 380,600,000 403,400,000 481,500,000 487,500,000 302,400,000 359,518,000 364,959,000 350,131,000 344,992,000 290,802,000 222,123,000 223,967,000 210,477,000 149,886,000 181,528,000 184,838,000 192,046,000 165,788,000 153,868,000 154,924,000 164,431,000 128,907,000 63,300,000 128,971,000 55,939,000 154,754,000 83,305,000 152,537,000 138,677,000 
      cash flows from investing activities:
    		                                                      
      other investing
    		  0 0                                                   
      proceeds from capital-related government incentives
    		300,000 4,800,000 300,000 0 0 100,000 4,900,000                                                
      investments in other assets
    		-27,100,000 -23,800,000 -42,100,000 -24,000,000 -45,800,000 -52,700,000 -36,000,000 -27,800,000 -19,500,000 -30,100,000 -38,600,000 -22,800,000 -20,500,000 -32,300,000 -30,000,000 -35,600,000 -29,700,000 -26,400,000 -15,900,000 -30,100,000 -35,400,000 -7,600,000 -31,000,000 -26,900,000 -11,000,000 -2,600,000 -5,800,000 -3,900,000 -7,300,000 -1,600,000 -1,716,000 -1,546,000 -1,905,000 -1,933,000 -6,365,000 -2,467,000 -765,000 -2,980,000 -1,215,000 -1,766,000 -1,615,000 -2,536,000 -1,123,000 -4,511,000 -1,335,000 -1,616,000 -1,814,000 -595,000 -1,609,000      
      capital expenditures
    		-36,500,000 -17,900,000 -14,200,000 -18,100,000 -20,800,000 -72,900,000 -40,100,000 -59,500,000 -74,400,000 -111,100,000 -112,700,000 -141,300,000 -110,300,000 -121,900,000 -114,600,000 -90,700,000 -78,500,000 -86,300,000 -55,400,000 -21,400,000 -6,300,000 -9,500,000 -11,900,000 -14,100,000 -17,700,000 -23,900,000 -40,100,000 -27,400,000 -72,000,000 -89,400,000 -58,388,000 -66,387,000 -59,895,000 -22,130,000 -15,692,000 -18,152,000 -18,494,000 -17,869,000 -29,943,000 -33,611,000 -36,642,000 -38,735,000 -44,637,000 -24,330,000 -27,449,000 -27,757,000 -9,864,000 -15,908,000 -10,304,000 -6,133,000 -25,230,000 -27,219,000 -24,340,000 -34,177,000 
      free cash flows
    		51,600,000 257,700,000 191,700,000 253,400,000 22,800,000 304,200,000 389,900,000 793,800,000 541,800,000 882,100,000 596,800,000 1,136,600,000 682,900,000 718,500,000 633,100,000 762,700,000 533,200,000 543,600,000 393,800,000 488,300,000 449,500,000 492,300,000 359,800,000 381,400,000 378,300,000 356,700,000 363,300,000 454,100,000 415,500,000 213,000,000 301,130,000 298,572,000 290,236,000 322,862,000 275,110,000 203,971,000 205,473,000 192,608,000 119,943,000 147,917,000 148,196,000 153,311,000 121,151,000 129,538,000 127,475,000 136,674,000 119,043,000 47,392,000 118,667,000 49,806,000 129,524,000 56,086,000 128,197,000 104,500,000 
      net cash from investing activities
    		-62,000,000 -36,900,000 -56,000,000 -42,100,000 -64,200,000 -125,500,000 -71,200,000 -86,200,000 -93,800,000 -140,900,000 -150,800,000 -164,100,000 -130,800,000 -153,800,000 -142,700,000 -126,300,000 -96,000,000 -112,700,000 -63,200,000 -51,500,000 -41,700,000 -16,900,000 -35,500,000 -43,000,000 -28,400,000 -26,300,000 -43,600,000 -31,400,000 -69,500,000 -6,666,500,000 -50,139,000 -369,588,000 -200,701,000 -391,272,000 -34,176,000 -20,591,000 -2,295,729,000 -53,908,000 -540,680,000 -187,189,000 -156,566,000 -247,763,000 -272,428,000 -64,837,000 -174,329,000 -209,193,000 -47,642,000 -951,055,000 77,890,000 -73,312,000 -72,214,000 -88,603,000 29,567,000 37,347,000 
      cash flows from financing activities:
    		                                                      
      proceeds from issuance of commercial paper
    		  3,370,400,000 4,212,900,000 2,780,800,000 3,573,400,000 5,480,800,000 2,563,300,000                                               
      repayments of commercial paper
    		-476,000,000 -174,100,000 -4,483,000,000 -4,460,300,000 -1,533,100,000 -4,637,500,000 -4,774,000,000                                                
      repayment of senior notes
    		  0 0   -1,400,000,000 0 -1,000,000,000 -1,000,000,000     0 0 0 -1,000,000,000                                     
      proceeds from issuance of convertible debt
    		  0 0 0 1,250,000,000                                                 
      deferred financing costs
    		  -1,700,000 -1,500,000 -900,000 -15,600,000 -1,500,000 -500,000       -700,000 -5,200,000 -500,000 -2,100,000 -2,900,000 -11,500,000 -1,600,000 -5,200,000 -7,100,000 0   0 0 -100,000 -72,600,000 8,000 -394,000      -1,750,000 0 -406,000    0 0 -7,515,000         
      purchase of capped call options
    		  -55,100,000 0 0 -105,000,000             0                                    
      proceeds from sale of common stock
    		17,900,000 12,400,000 20,000,000 11,800,000 20,500,000 13,100,000 24,400,000 17,100,000 25,300,000 15,300,000 28,000,000 16,500,000 24,400,000 13,400,000 23,400,000 13,700,000 21,200,000 12,200,000 20,100,000 10,600,000 18,600,000 11,000,000 20,000,000 11,300,000 20,200,000 7,300,000 15,700,000 6,600,000 13,800,000 6,500,000 15,424,000 7,008,000 15,094,000 4,474,000 3,441,000 20,822,000 4,630,000 4,396,000 10,023,000 3,497,000 6,794,000 9,910,000 4,125,000 2,556,000 15,296,000 6,900,000 6,301,000 11,357,000 4,961,000 14,743,000 7,395,000 18,272,000 20,593,000 29,078,000 
      tax payments related to shares withheld for vested rsus
    		-11,600,000 -8,400,000 -12,600,000 -11,800,000 -14,300,000 -18,900,000 -14,200,000 -16,500,000 -14,700,000 -15,700,000 -18,600,000 -17,100,000 -20,700,000 -19,400,000 -17,300,000 -17,800,000                                       
      repurchase of common stock
    		  0 -6,500,000 -17,300,000 -72,700,000 -387,400,000 -114,600,000 -339,800,000 -140,300,000 -273,900,000 -229,500,000 -247,200,000 -195,200,000 -259,600,000                       0                 
      payment of cash dividends on series a preferred stock
    		-27,800,000 -25,100,000                                                     
      payment of cash dividends on common stock
    		-245,800,000 -245,500,000                                                     
      capital lease payments
    		-400,000 -400,000 -400,000 -400,000 -400,000 -400,000 -400,000 -400,000 -400,000 -400,000 -200,000 -200,000 -200,000 -200,000 -200,000 -200,000 -200,000 -200,000 0 -200,000 -200,000 -200,000 -200,000 -200,000 -200,000 -200,000 -200,000 -200,000 -200,000 -200,000 -213,000 -196,000 -196,000 -195,000 -196,000 -196,000 -195,000 -170,000 -168,000 -166,000 -152,000 -150,000 -148,000 -135,000 -134,000 -44,000         
      other financing
    		-500,000 -2,800,000 -2,800,000                                                    
      net cash from financing activities
    		-355,800,000 -443,900,000 35,800,000 70,500,000 -8,400,000 -256,200,000 -320,100,000 -742,700,000 -537,000,000 -815,100,000 -613,600,000 -1,129,700,000 -734,700,000 -626,900,000 -601,100,000 -666,900,000 -540,100,000 -519,500,000 -476,700,000 -455,800,000 -424,000,000 -507,700,000 -332,300,000 -357,200,000 -399,800,000 -348,900,000 -363,400,000 -477,600,000 -593,500,000 6,098,000,000 -80,174,000 -149,699,000 -96,059,000 -89,368,000 -82,043,000 -312,174,000 580,015,000 -364,196,000 366,325,000 -38,607,000 -53,372,000 -80,413,000 257,807,000 -58,133,000 -39,624,000 -80,341,000 -52,354,000 543,303,000 -62,768,000 -52,031,000 -58,794,000 -47,243,000 21,204,000 -99,129,000 
      net decrease in cash and cash equivalents
    		-329,700,000 -205,200,000               -24,400,000 -2,300,000 -90,700,000 2,400,000   3,900,000 -4,700,000        -154,328,000 53,371,000 -135,648,000 173,950,000 -110,538,000 -1,492,225,000       30,898,000   28,558,000        
      cash and cash equivalents, at beginning of period
    		0 771,700,000 0                                                    
      cash and cash equivalents, at end of period
    		-329,700,000 566,500,000 185,700,000                                                    
      decrease in inventories
    		 125,000,000                 900,000                                    
      increase in accounts payable and accrued liabilities
    		 27,600,000   -141,100,000 -41,200,000 -124,400,000 -88,000,000 29,100,000 34,900,000 97,900,000 81,200,000 -8,100,000 152,400,000 118,900,000 70,500,000   11,000,000   -46,600,000    49,700,000  -105,700,000 -35,600,000 -2,200,000  15,976,000 -10,525,000 36,331,000   -18,000,000   16,157,000   -4,415,000   3,909,000   4,766,000  -32,513,000 -17,787,000 18,641,000 -22,607,000 
      loss on settlement of debt
    		  1,400,000    0 0 3,100,000 9,100,000 0 0 2,100,000 6,200,000 11,800,000 16,100,000 85,200,000 300,000 85,600,000 142,100,000 45,100,000 26,800,000 3,400,000 0 100,000 1,900,000 8,300,000 200,000                           
      decrease (increase) in accounts receivable
    		  167,500,000 187,100,000 51,500,000 47,900,000                39,700,000     49,400,000 124,000,000                      -6,868,000     
      proceeds from borrowings on revolving credit facility
    		      720,000,000 0 2,966,000,000 2,585,000,000 1,914,000,000 1,256,000,000 1,459,000,000 1,306,000,000 1,229,000,000 1,002,000,000                                       
      repayments of revolving credit facility
    		      -720,000,000 -39,000,000 -3,652,000,000 -1,960,000,000 -2,067,000,000 -1,975,100,000 -1,687,000,000 -1,505,000,000 -1,370,000,000 -1,268,500,000                                       
      proceeds from borrowings on 2025 term loan facility
    		      0 0                                               
      repayments of 2025 term loan facility
    		  0                                                    
      proceeds from issuance of senior notes
    		  0            0 0 0 997,000,000 0 1,395,800,000 0 2,182,000,000                                 
      payments on settlement of convertible debt
    		  -3,700,000    0 0 -42,700,000 -90,100,000 0 0 -96,900,000 -73,500,000 -64,900,000 -96,200,000   -359,200,000 -428,900,000 -796,100,000 -1,027,200,000         21,000                        
      issuance of series a preferred stock
    		                                                      
      payment of cash dividends
    		  -244,800,000 -244,600,000 -243,700,000 -242,600,000 -242,500,000 -237,400,000 -222,700,000 -208,900,000 -195,900,000 -180,300,000 -166,100,000 -153,000,000 -140,800,000 -128,700,000 -121,200,000 -113,100,000 -106,600,000 -96,000,000 -95,300,000 -90,400,000 -88,000,000 -87,700,000 -87,300,000 -87,100,000 -86,600,000 -86,400,000 -85,900,000 -85,500,000 -85,140,000 -84,912,000 -84,520,000 -82,928,000 -77,970,000 -77,640,000 -77,237,000 -72,923,000 -72,685,000 -72,331,000 -71,787,000 -71,442,000 -71,202,000 -70,554,000           
      net increase in cash and cash equivalents
    		  185,700,000 299,900,000 -29,000,000 -4,600,000 38,700,000 24,400,000 -14,600,000 37,200,000 -54,900,000   59,700,000 3,900,000       -22,800,000    5,400,000             -24,469,000 -44,268,000  -136,331,000 151,167,000   -125,103,000   144,093,000   -52,541,000 203,308,000 76,895,000 
      increase in inventories
    		   -16,800,000     5,500,000 -10,600,000 -158,400,000 -134,600,000 -125,200,000 -65,000,000 -72,800,000 -55,200,000 -30,600,000 -19,200,000       300,000 -20,500,000     10,983,000 -30,034,000 -30,245,000 -9,904,000     19,296,000 -23,893,000    1,515,000 -18,146,000 -13,957,000    -6,223,000 -8,690,000 -21,384,000 -1,289,000 -10,744,000 
      cash and cash equivalents, and restricted cash at beginning of period
    		    0 319,700,000 0 0 0 234,000,000 0 0 0 317,400,000 0 0 0 280,000,000 0 0 0 401,000,000 0 0 0 428,600,000 0 0 0 901,300,000                         
      cash and cash equivalents, and restricted cash at end of period
    		    -29,000,000 315,100,000 38,700,000 24,400,000 -14,600,000 271,200,000 -54,900,000 -15,900,000 -72,300,000 377,100,000 3,900,000 60,200,000 -24,400,000 277,700,000 -90,700,000 2,400,000 -9,900,000 378,200,000 3,900,000 -4,700,000   -3,600,000 -27,500,000 -175,500,000 635,200,000                         
      proceeds from sales of assets
    		      0 0 100,000 300,000 500,000 0 0 400,000 1,900,000 0                                       
      supplemental disclosure of cash flow information:
    		                                                      
      non-cash activities:
    		                                                      
      rou assets obtained in exchange of lease liabilities
    		                                                      
      other non-cash adjustment
    		        0 -100,000 0 500,000 -2,100,000 -200,000 -1,900,000 -5,600,000 -4,800,000 900,000  0 400,000 500,000    -100,000                             
      repayment of bridge loan facility
    		                  0 0 0 -615,000,000                                 
      repayments of term loan facility
    		                  0 -1,705,700,000 0 -17,800,000 0 0 0 -188,000,000 -801,500,000 -20,000,000                           
      cash paid for:
    		                                                      
      purchases of available-for-sale investments
    		                      0    0 0 0 -167,700,000 -256,660,000 -458,703,000 -392,002,000 -487,435,000 -35,122,000 0 -25,000 -430,775,000 -541,588,000 -570,501,000 -371,263,000 -178,092,000 -172,506,000 -240,363,000 -333,737,000 -376,460,000 -203,318,000 -413,976,000 -29,130,000 -296,404,000 -340,822,000 -324,893,000 -148,749,000 -62,430,000 
      sales of available-for-sale investments and marketable equity securities
    		                                                      
      proceeds from borrowings on bridge loan facility
    		                                                      
      decrease in accounts receivable
    		               55,500,000    9,900,000    41,100,000                               
      proceeds from sale of assets
    		                  8,100,000 0 0 200,000 2,700,000 0 300,000 200,000 0 100,000 0 100,000 11,000 48,000 15,000 10,226,000 23,003,000 14,000 52,000 0 13,669,000 627,000    0 0 16,200,000 240,000 16,000 50,000 164,000   1,109,000 2,129,000 
      proceeds from borrowings on revolving loan under credit facility
    		                 775,000,000 893,000,000 869,000,000 966,000,000 1,238,000,000 344,000,000 255,000,000 223,000,000 204,000,000 691,000,000 93,000,000 147,000,000 3,485,500,000 0 74,000,000 53,000,000 60,000,000 132,000,000 105,000,000 1,280,000,000 93,000,000 879,500,000 145,000,000               
      repayments of revolving loan under credit facility
    		                 -1,163,000,000 -903,000,000 -432,000,000 -501,000,000 -2,171,900,000 -580,000,000 -512,000,000 -538,500,000 -273,500,000 -167,000,000 -450,500,000 -381,000,000 -151,500,000 0 -74,000,000 -53,000,000 -60,000,000 -127,000,000 -349,500,000 -602,000,000 -381,000,000 -80,000,000 -110,000,000               
      tax payments related to shares withheld for vested restricted stock units
    		                 -25,300,000 -18,100,000 -21,100,000 -14,400,000 -11,000,000 -17,900,000 -23,600,000 -15,200,000 -11,400,000 -14,800,000 -20,100,000 -20,100,000 -16,800,000 -10,274,000 -12,950,000 -10,457,000 -10,719,000 -12,318,000 -10,660,000 -25,183,000 -6,077,000 -6,660,000 -4,464,000 -3,970,000 -5,338,000 -4,968,000            
      losses on equity method investments
    		                          0 100,000 0 100,000 33,000 56,000 56,000 55,000 55,000 56,000 56,000 56,000 56,000 177,000 62,000 35,000 32,000 -150,000 101,000 260,000 229,000 32,000 121,000  13,000 61,000   
      gains on sale of assets
    		                    0 -900,000         -479,000 -40,000 -816,000 -4,565,000 -3,000 -14,000 -61,000                  
      losses on write-down of fixed assets
    		                      0    300,000     7,000 5,000 48,000 961,000                    
      gains on equity investments
    		                  0                                    
      impairment of available-for-sale investments
    		                                                      
      amortization of premium on available-for-sale investments
    		                          0 0 0 -200,000 -231,000 -62,000 117,000 476,000   13,000 2,498,000 2,336,000 2,396,000 2,495,000 2,477,000 2,589,000            
      maturities of available-for-sale investments
    		                          2,300,000 -200,000 9,200,000 66,700,000 266,614,000 157,000,000                       
      acquisition of microsemi, net of cash acquired
    		                          0 0 600,000 -7,851,200,000                         
      proceeds from borrowings on term loan facility
    		                          0 0 0 3,000,000,000                         
      repayment of debt assumed in microsemi acquisition
    		                          0 0 0 -2,056,900,000                         
      restricted cash
    		                                                      
      interest
    		                                                      
      income taxes
    		                                                      
      operating lease payments in operating cash flows
    		                                                      
      during the fiscal year ended march 31, 2021, the company completed the december 2020 settlement of 1,086.5 million principal amount of convertible debt in exchange for 428.9 million in cash, 8.4 million shares of common stock and 665.5 million principal amount of 2020 senior convertible debt. refer to note 7 for further information.
    		                                                      
      during the fiscal year ended march 31, 2020, the company adopted accounting standards codification topic 842, leases, using the retrospective cumulative effect adjustment transition method. the disclosures are not applicable for the fiscal year ended march 31, 2019.
    		                                                      
      (gains) losses on sale of assets
    		                                                      
      during the nine months ended december 31, 2020, the company completed the december 2020 settlement of 1,086.5 million principal amount of convertible debt in exchange for 428.9 million in cash, 8.4 million shares of common stock and 665.5 million principal amount of 2020 senior convertible debt. refer to note 6 for further information.
    		                                                      
      gains on available-for-sale investments and marketable equity securities
    		                    0 -200,000                                 
      supplemental disclosure of cash flow information
    		                                                      
      gains on marketable equity securities
    		                                                      
      increase in deferred income on shipments to distributors
    		                              -1,890,000 11,342,000 15,566,000 15,982,000 71,063,000 10,025,000 29,739,000 -16,380,000 12,091,000 1,401,000 -5,321,000 13,002,000 -1,215,000 -7,734,000 1,232,000 10,865,000 -511,000 953,000 2,084,000 -28,399,000 -1,413,000 5,554,000 -2,641,000 10,403,000 
      proceeds from issuance of 2023 and 2021 senior notes
    		                          0 0 0 1,989,500,000                         
      right-of-use assets obtained in exchange of lease liabilities
    		                                                      
      losses on sale of assets
    		                                                      
      (gains) losses on available-for-sale investments and marketable equity securities
    		                       0 -200,000 -800,000                             
      sales of available-for-sale investments
    		                          0 0 0 1,376,600,000                         
      losses on available-for-sale investments and marketable equity securities
    		                                                      
      realized gain on equity method investment
    		                                     0 0 -2,225,000               
      impairment of available-for-sale investment
    		                                                      
      operating cash flows related to discontinued operations
    		                                  -966,000 4,318,000 5,996,000                  
      sale of equity method investment
    		                                  0 0 468,000 0 0 2,667,000               
      acquisition of atmel, net of cash acquired
    		                                  0 0 -2,747,516,000                  
      proceeds from issuance of 2017 senior convertible debt
    		                                                      
      proceeds from issuance of 2017 junior convertible debt
    		                                                      
      effect of foreign exchange rate changes on cash and cash equivalents
    		                                  -633,000 104,000 -478,000    0      -353,000        
      net decrease in cash, cash equivalents, and restricted cash
    		                           -27,500,000 -175,500,000 -266,100,000                         
      amortization of debt discount on convertible debt
    		                            27,900,000 27,500,000 27,083,000 26,711,000 26,353,000 25,953,000                     
      losses on available-for-sale investments
    		                            1,000,000 5,200,000                         
      loss on settlement of convertible debt
    		                              34,000 2,140,000 0 13,826,000                     
      other non-cash adjustments
    		                             -100,000                         
      excess tax benefit from share-based compensation
    		                                     -328,000 -144,000 -263,000 -118,000      -42,000 -92,000 -20,000 -39,000 -17,000 -385,000 -614,000  
      loss on write-down of fixed assets
    		                                    269,000                  
      realized losses (gain) on available-for-sale investments
    		                                                      
      acquisition of micrel, net of cash acquired
    		                                     0                 
      purchase of additional controlling interest in issc
    		                                     0 0 -18,051,000 -21,169,000              
      proceeds from issuance of 2017 senior debt
    		                                                      
      proceeds from issuance of 2017 junior debt
    		                                                      
      cash and cash equivalents at beginning of period
    		                              16,000 0 0 908,684,000 0 0 2,092,751,000 0 0 607,815,000 0 0 466,603,000 0 0 528,334,000 0 0 635,755,000 0 0 703,924,000  0 
      cash and cash equivalents at end of period
    		                              229,221,000 -154,328,000 53,371,000 773,036,000 173,950,000 -110,538,000 600,526,000 -207,627,000 -24,469,000 563,547,000 -25,100,000 -136,331,000 617,770,000 30,898,000 -59,029,000 403,231,000 28,558,000 -343,113,000 779,848,000 -69,404,000 23,746,000 651,383,000  76,895,000 
      realized losses on available-for-sale investment
    		                                                      
      realized gains on equity method investment
    		                                  0 0 -468,000                  
      payments on conversion of convertible debt
    		                                                      
      (increase) in accounts receivable
    		                                 -50,581,000                     
      sales and maturities of available-for-sale investments
    		                                 110,000,000 0 14,000 470,551,000 397,716,000 362,325,000 433,446,000 274,123,000 225,834,000 321,203,000 213,380,000 188,192,000 182,614,000 167,114,000 211,154,000 139,439,000 230,793,000 297,960,000 264,485,000 216,291,000 145,235,000 
      amortization of debt discount on convertible debentures
    		                                  12,494,000 12,307,000 12,106,000 12,163,000 11,974,000 11,772,000 2,501,000 2,445,000 2,365,000 2,286,000 2,235,000 2,161,000 2,089,000 2,042,000 1,975,000 1,909,000 1,866,000 1,805,000 1,746,000 1,745,000 
      realized losses (gains) on available-for-sale investment
    		                                  0 7,000 82,000                  
      special charges (income) and other
    		                                                      
      special charges
    		                                     840,000                 
      gain on sale of assets
    		                                     -100,000 -300,000 -560,000       -240,000   -164,000   0 -50,000 
      realized gain on available-for-sale investment
    		                                     -95,000 0 -13,959,000               
      changes in operating assets and liabilities:
    		                                                      
      acquisition of issc, net of cash acquired
    		                                        0              
      acquisition of supertex, net of cash acquired
    		                                        0 0 -375,365,000            
      repayments of long-term borrowings
    		                                        -4,375,000 -4,375,000 -4,375,000            
      convertible debt derivatives - revaluation and amortization
    		                                        33,000 57,000 -11,000 -201,000 -264,000 16,000 -336,000 259,000 330,000 61,000 396,000 -30,000  -249,000 
      special income
    		                                           -762,000           
      gain on shares of acquired company
    		                                                      
      other business acquisitions, net of cash acquired
    		                                           -9,013,000   0        
      repayments of revolving loan under previous credit facility
    		                                           0 0 -650,000,000         
      repayments of revolving loan under new credit facility
    		                                        -119,400,000 -138,500,000 -170,000,000 -83,500,000           
      proceeds from borrowings on revolving loan under previous credit facility
    		                                           0 0 30,000,000         
      proceeds from borrowings on revolving loan under new credit facility
    		                                        139,400,000 128,500,000 504,375,000 93,500,000 100,000,000 260,000,000         
      proceeds from issuance of long-term borrowings
    		                                           0 0 350,000,000         
      contingent consideration payment
    		                                           0           
      special charge
    		                                             1,392,000         
      unrealized impairment loss on available-for-sale investments
    		                                              78,000   204,000 2,064,000 945,000 3,396,000 422,000 
      acquisition of smsc, net of cash acquired
    		                                              0        
      business acquisitions, net of cash acquired
    		                                             -2,174,000         
      payment of cash dividend
    		                                             -69,682,000 -68,697,000 -68,146,000 -67,749,000 -66,813,000 -66,206,000 -65,900,000 -3,000 -129,447,000 
      amortization of convertible debenture issuance costs
    		                                              55,000 55,000 54,000 55,000 55,000 55,000  55,000 
      proceeds from borrowings on line of credit
    		                                              10,000,000        
      business acquisitions
    		                                                -20,556,000      
      losses (gains) on equity method investments
    		                                                      
      purchase of silicon storage technology, inc., net of cash received
    		                                                     0 
      investment in other assets
    		                                                  -4,170,000 -976,000 -14,744,000 -13,410,000 
      adjustments to reconcile net income to net cash from operating
    		                                                      
      activities:
    		                                                      
      convertible debt derivatives – revaluation and amortization
    		                                                      
      amortization of junior convertible debenture issuance costs
    		                                                      
      gains on equity method investments
    		                                                    28,000  
      sales (purchases) of trading securities
    		                                                      
      (gain) loss on trading securities
    		                                                      
      purchase of silicon storage technology, net of cash received
    		                                                      
      investment in silicon storage technology
    		                                                      
      cash and cash equivalents at beginning of year
    		                                                      
      cash and cash equivalents at end of year
    		                                                      
      see accompanying notes to consolidated financial statements
    		                                                      
      sales of trading securities
    		                                                      
      gain on trading securities
    		                                                      
      see accompanying notes to condensed consolidated financial statements
    		                                                      
      
    		                                                      
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.